ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
114.51
+3.87 (3.50%)
At close: Dec 5, 2025, 4:00 PM EST
117.80
+3.29 (2.87%)
After-hours: Dec 5, 2025, 7:56 PM EST
ABIVAX Société Anonyme Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for ABIVAX Société Anonyme stock have an average target of 112.83, with a low estimate of 33 and a high estimate of 176. The average target predicts a decrease of -1.47% from the current stock price of 114.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ABIVAX Société Anonyme stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 2 | 6 | 6 | 7 | 8 | 9 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 8 | 8 | 9 | 10 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $140 | Strong Buy | Initiates | $140 | +22.26% | Nov 24, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $176 | Buy | Initiates | $176 | +53.70% | Nov 6, 2025 |
| Barclays | Barclays | Buy Initiates $142 | Buy | Initiates | $142 | +24.01% | Oct 13, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $101 → $150 | Strong Buy | Maintains | $101 → $150 | +30.99% | Oct 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $112 → $120 | Strong Buy | Maintains | $112 → $120 | +4.79% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
11.53M
from 10.79M
Increased by 6.80%
Revenue Next Year
8.14M
from 11.53M
Decreased by -29.35%
EPS This Year
-2.75
from -2.80
EPS Next Year
-0.64
from -2.75
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 31.5M | 13.0M | ||||
| Avg | 11.5M | 8.1M | ||||
| Low | 3.9M | 3.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 191.9% | 13.0% | ||||
| Avg | 6.8% | -29.4% | ||||
| Low | -63.7% | -66.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.32 | 10.54 | |
| Avg | -2.75 | -0.64 | |
| Low | -3.39 | -3.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.